Accuray Achieves Patient Treatment Milestone on Third Anniversary of National Prostate Cancer Awareness Month SUNNYVALE, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 1,000 men have been
SUNNYVALE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and CEO, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at the UBS Global Life Sciences Conference at the
Worldwide Availability of Monte Carlo Dose Calculation Software Announced at European Radiation Oncology Meeting in Barcelona BARCELONA, Spain, Sept. 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Monte Carlo
SUNNYVALE, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), today announced that its Board of Directors has approved a plan that authorizes the Company to repurchase shares of its common stock. Under the plan, the Company will have the ability to acquire up to $25
Click here for PDF version of this release - Revenue Growth of 166 Percent Year Over Year - - Total Backlog Reaches Record Level of $619 Million - SUNNYVALE, Calif., Aug 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), the global leader in radiosurgery
U.S. Patients Treated with CyberKnife System for Lung Cancer Doubled and Prostate Cancer Quadrupled SUNNYVALE, Calif., Aug. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that use of its CyberKnife(R) Robotic
Monte Carlo Dose Calculation Extends CyberKnife(R) System's Capabilities in Precision Radiation Delivery for Lung Tumors SUNNYVALE, Calif., July 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Accuray's Xsight(TM)
SUNNYVALE, Calif., July 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will report results for its fourth quarter fiscal year 2007 ending June 30, 2007 and full fiscal year 2007 ending
SUNNYVALE, Calif., June 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Euan S. Thomson, Ph.D, president and chief executive officer and Robert E. McNamara, senior vice president and chief financial officer are
Independent Data Confirms CyberKnife System is Only Radiosurgery Solution in Widespread Use for Extracranial Radiosurgery SUNNYVALE, Calif., June 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the latest utilization
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
